Nakayama E - Search Results

1

Sequential involvement of two distinct CD4+ regulatory T cells during the course of transplantable tumor growth and protection from 3-methylcholanthrene-induced tumorigenesis by CD25-depletion.

Tawara I, Take Y, Uenaka A, Noguchi Y, Nakayama E. Tawara I, et al. Among authors: nakayama e. Jpn J Cancer Res. 2002 Aug;93(8):911-6. doi: 10.1111/j.1349-7006.2002.tb01337.x. Jpn J Cancer Res. 2002. PMID: 12716469 Free PMC article.

2

Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells.

Ota S, Ono T, Morita A, Uenaka A, Harada M, Nakayama E. Ota S, et al. Among authors: nakayama e. Cancer Res. 2002 Mar 1;62(5):1471-6. Cancer Res. 2002. PMID: 11888922

3

Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice.

Win S, Uenaka A, Nakayama E. Win S, et al. Among authors: nakayama e. Microbiol Immunol. 2002;46(7):513-9. doi: 10.1111/j.1348-0421.2002.tb02728.x. Microbiol Immunol. 2002. PMID: 12222940 Free article.

4

Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).

Uenaka A, Nakayama E. Uenaka A, et al. Among authors: nakayama e. Cancer Sci. 2003 Nov;94(11):931-6. doi: 10.1111/j.1349-7006.2003.tb01380.x. Cancer Sci. 2003. PMID: 14611667 Free PMC article. Review.

5

Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T-lymphocytes and the GM-CSF gene by in vivo electroporation.

Tanaka M, Yamada M, Ono T, Noguchi Y, Uenaka A, Ota S, Hata H, Harada M, Tanimoto M, Nakayama E. Tanaka M, et al. Among authors: nakayama e. Cancer Sci. 2004 Feb;95(2):154-9. doi: 10.1111/j.1349-7006.2004.tb03197.x. Cancer Sci. 2004. PMID: 14965366 Free PMC article.

6

Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.

Takada I, Noguchi Y, Kenjo A, Wada H, Uenaka A, Fujita T, Inoue H, Nakayama E. Takada I, et al. Among authors: nakayama e. Cancer Sci. 2004 Mar;95(3):254-9. doi: 10.1111/j.1349-7006.2004.tb02212.x. Cancer Sci. 2004. PMID: 15016326 Free PMC article.

7

Identification of a CD4 T-cell epitope in tumor rejection antigen RLakt on BALB/c radiation-leukemia RL male 1.

Kaya S, Uenaka A, Sato S, Ono T, Aji T, Nakayama E. Kaya S, et al. Among authors: nakayama e. Cancer Sci. 2008 Jul;99(7):1441-7. doi: 10.1111/j.1349-7006.2008.00843.x. Epub 2008 Apr 29. Cancer Sci. 2008. PMID: 18452555 Free PMC article.

8

[Analysis of tumor rejection antigen peptides recognized by specific CTL].

Uenaka A, Nakayama E. Uenaka A, et al. Among authors: nakayama e. Nihon Rinsho. 1996 Jan;54(1):242-9. Nihon Rinsho. 1996. PMID: 8587197 Review. Japanese.

9

Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.

Ono T, Uenaka A, Nakayama E. Ono T, et al. Among authors: nakayama e. Jpn J Cancer Res. 1996 Nov;87(11):1165-70. doi: 10.1111/j.1349-7006.1996.tb03127.x. Jpn J Cancer Res. 1996. PMID: 9045946 Free PMC article.

10

Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.

Manki A, Ono T, Uenaka A, Seino Y, Nakayama E. Manki A, et al. Among authors: nakayama e. Cancer Res. 1998 May 1;58(9):1960-4. Cancer Res. 1998. PMID: 9581839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters